Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines

被引:15
作者
Dan, S
Shirakawa, M
Mukai, Y
Yoshida, Y
Yamazaki, K
Kawaguchi, T
Matsuura, M
Nakamura, Y
Yamori, T
机构
[1] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Pharmacol, Toshima Ku, Tokyo 1708455, Japan
[2] Japanese Fdn Canc Res, Dept Pathol, Inst Canc, Toshima Ku, Tokyo 1708455, Japan
[3] Japanese Fdn Canc Res, Genome Ctr, Bioinformat Ctr, Toshima Ku, Tokyo 1708455, Japan
[4] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan
关键词
D O I
10.1111/j.1349-7006.2003.tb01403.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously investigated the correlations between the expression of 9216 genes and various chemosensitivities in a panel of 39 human cancer cell lines(1)) and found that the expression levels of AKR1B1 and CTSH were correlated with sensitivity and resistance to multiple drugs, respectively. To validate these correlations, we investigated the expression of these two genes and the chemosensitivities in 12 additional gastric cancer cell lines. The expression of AKR1B1 in the additional cell lines exhibited significant correlations with sensitivities to 8 of the 23 drugs examined, while that of CTSH displayed a significant negative correlation with only one (MS-247) of the 27 drugs examined. Their expressions were weakly correlated with sensitivity and resistance, respectively, to the remainder of the drugs. Moreover, when the 12 cell lines were divided into high-expressing and low-expressing groups, a comparison of these groups using Mann-Whitney's U test revealed that high expression levels of AKR1B1 and CTSH were related to sensitivity to 21 of the drugs and resistance to 8 of the drugs, respectively. The present results suggest that AKR1B1 and CTSH may be good markers for prediction of sensitivity to certain drugs and that our panel of 39 cell lines has the potential to identify candidate predictive marker genes.
引用
收藏
页码:1074 / 1082
页数:9
相关论文
共 32 条
[1]   CHARACTERISTICS OF 3 HUMAN GASTRIC-CANCER CELL-LINES, NU-GC-2, NU-GC-3 AND NU-GC-4 [J].
AKIYAMA, S ;
AMO, H ;
WATANABE, T ;
MATSUYAMA, M ;
SAKAMOTO, J ;
IMAIZUMI, M ;
ICHIHASHI, H ;
KONDO, T ;
TAKAGI, H .
JAPANESE JOURNAL OF SURGERY, 1988, 18 (04) :438-446
[2]   Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction [J].
Ax, W ;
Soldan, M ;
Koch, L ;
Maser, E .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (03) :293-300
[3]  
BARRANCO SC, 1983, CANCER RES, V43, P1703
[4]   Pharmacogenomic analysis: Correlating molecular substructure classes with microarray gene expression data [J].
Blower P.E. ;
Yang C. ;
Fligner M.A. ;
Verducci J.S. ;
Yu L. ;
Richman S. ;
Weinstein J.N. .
The Pharmacogenomics Journal, 2002, 2 (4) :259-271
[5]  
BOHREN KM, 1989, J BIOL CHEM, V264, P9547
[6]  
Dan S, 2002, CANCER RES, V62, P1139
[7]  
del Re EC, 2000, BRIT J CANCER, V82, P1317
[8]   Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring [J].
Golub, TR ;
Slonim, DK ;
Tamayo, P ;
Huard, C ;
Gaasenbeek, M ;
Mesirov, JP ;
Coller, H ;
Loh, ML ;
Downing, JR ;
Caligiuri, MA ;
Bloomfield, CD ;
Lander, ES .
SCIENCE, 1999, 286 (5439) :531-537
[9]   Genome-wide views of cancer. [J].
Golub, TR .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (08) :601-602
[10]   Overexpression of the aldose reductase gene induces apoptosis in pancreatic β-cells by causing a redox imbalance [J].
Hamaoka, R ;
Fujii, J ;
Miyagawa, J ;
Takahashi, M ;
Kishimoto, M ;
Moriwaki, M ;
Yamamoto, K ;
Kajimoto, Y ;
Yamasaki, Y ;
Hanafusa, T ;
Matsuzawa, Y ;
Taniguchi, N .
JOURNAL OF BIOCHEMISTRY, 1999, 126 (01) :41-47